title: Propofol or sevoflurane anaesthesia does not affect hepatic integrity as assessed by the M30 & M65 cell death markers & liver enzymes.
abstract: OBJECTIVE
  General anaesthetics may induce apoptosis. The pro-apoptotic/necrotic markers M30 (caspase-cleaved cytokeratin-18) and M65 (intact cytokeratin-18) have been used to identify early apoptosis in liver disease. The aim of this study was to detect the effect of propofol and sevoflurane anaesthesia on these markers and blood transaminase levels in female patients undergoing elective surgery.
  
  
  METHODS
  Sixty-seven women undergoing mastectomy or thyroidectomy under general anaesthesia were randomly allocated to the propofol or sevoflurane groups. Venous blood samples for measuring the apoptotic and necrotic markers M30 and M65 as well as for measuring the alanine aminotransferase (ALT) and the aspartate aminotransferase (AST) liver enzymes were collected before induction of anaesthesia, immediately after completion of surgery, and 24 and 48 h postoperatively.
  
  
  RESULTS
  The M30 values preoperatively and 0, 24 and 48 h postoperatively were 280±229, 300±244, 267±198 and 254±189 U/l in the propofol group and 237±95, 242±109, 231±94 and 234±127 U/l in the sevoflurane group, respectively. The M30 values did not differ within or between the groups. The M65 levels at the same time intervals were 470±262, 478±271, 456±339 and 485±273 in the propofol group and 427±226, 481±227, 389±158 and 404±144 U/l in the sevoflurane group, respectively. No significant changes were found in the M65 either within or between the propofol and the sevoflurane groups. The ALT and AST levels did not change at these time intervals.
  
  
  CONCLUSIONS
  Under the present study design propofol or sevoflurane anaesthesia did not induce apoptosis or affected the liver function as assessed by the M30, M65 markers and liver enzymes in patients undergoing mastectomy or thyroidectomy under general anaesthesia.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Chondrogiannis
authors.forename: Emilia
authors.initials: E
authors.lastname: Hadziyannis
authors.affiliation: Department of Anaesthesia, Aretaieio Hospital, University of Athens, Athens, Greece.
authors.forename: Argyro
authors.initials: A
authors.lastname: Fassoulaki
mesh_terms: D000368:Aged; D000410:Alanine Transaminase / Q000378:metabolism; D000758:Anesthesia / Q000009:adverse effects* / Q000379:methods; D017209:Apoptosis / Q000187:drug effects; D001219:Aspartate Aminotransferases / Q000378:metabolism; D005260:Female; D006801:Humans; D053538:Keratin-18 / Q000097:blood*; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008408:Mastectomy / Q000379:methods; D008738:Methyl Ethers / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D009336:Necrosis / Q000139:chemically induced / Q000201:enzymology / Q000473:pathology; D010446:Peptide Fragments / Q000097:blood*; D015742:Propofol / Q000008:administration & dosage / Q000009:adverse effects; D000077149:Sevoflurane; D013965:Thyroidectomy / Q000379:methods
chemical_list: D053538:Keratin-18; C561463:M30 cytokeratin-18 peptide, human; C577325:M65 antigen, human; D008738:Methyl Ethers; D010446:Peptide Fragments; D000077149:Sevoflurane; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D015742:Propofol